
Oncology Programme will accelerate cancer drug discovery
Biometrics contract research organisation (CRO) Phastar has joined Lean Life Science’s Oncology Development Programme (ODP2). The targeted programme aims to identify and accelerate novel oncology innovations into commercially-attractive assets by offering support to academics and early-stage companies. In collaboration with global pharma companies, Cancer Research… Read More












